Riskpilot← Back to searchSign inGet full accessNEUROKLINIK ApS
APSActiveCVR 28868790Egsagervej 9Physiotherapy activities · NACE 8695Est. 20056 employees
Revenue 2024
DKK 2,4M
+14% vs 2023
EBITDA margin
4.8%
-45% vs 2023
Equity ratio
68.0%
Financial strength
Net profit 2024
DKK 82K
-47% vs 2023
| Revenue | DKK 2,4M | +14% |
| EBITDA | DKK 115K | -45% |
| Net profit | DKK 82K | -47% |
| Total assets | DKK 1,1M | +14% |
| Equity | DKK 757K | +12% |
| Employees | 6 | — |
Legal name
NEUROKLINIK ApS
CVR number
28868790
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
1. juli 2005
Share capital
DKK 150.000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive neurologisk klinik samt tilbyde og afholde kurser indenfor neurologi og lignende virksomhed, der af direktionen skønnes forenelig med selskabets førnævnte formål.
Address
Egsagervej 9
Phone
+4535111134
Email
nk@neuroklinik.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.380 | 1.005 | 1.248 | 1.330 | 1.472 | 1.046 | 1.348 | 1.885 | 2.068 | 2.012 | 2.289 | 2.108 | 2.397 |
| Staff expenses | -1.562 | -714 | -1.053 | -1.177 | -1.406 | -800 | -1.110 | -1.576 | -1.724 | -1.715 | -2.008 | -1.900 | -2.283 |
| EBITDA | -182 | 291 | 195 | 214 | 67 | 247 | 238 | 309 | 344 | 297 | 281 | 207 | 115 |
| Depreciation & amort. | -69 | -26 | -7 | 30 | -105 | -0 | -11 | -12 | -19 | -19 | -19 | -8 | -7 |
| EBIT | -251 | 265 | 188 | 183 | -38 | 247 | 227 | 297 | 325 | 277 | 262 | 199 | 107 |
| Net financials | -1 | -3 | -2 | -27 | -9 | -3 | -2 | -3 | -8 | 1 | 19 | -1 | 1 |
| Profit before tax | -253 | 262 | 186 | 157 | -47 | 244 | 225 | 295 | 317 | 278 | 280 | 198 | 108 |
| Tax | -0 | -7 | 65 | 28 | -7 | 54 | 50 | 65 | 70 | 62 | 62 | 45 | 26 |
| Net profit | -253 | 269 | 121 | 128 | -40 | 190 | 175 | 230 | 247 | 216 | 218 | 154 | 82 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 276 | 606 | 648 | 953 | 709 | 538 | 567 | 756 | 1.249 | 1.279 | 1.004 | 974 | 1.112 |
| Equity | 118 | 387 | 459 | 488 | 347 | 340 | 326 | 380 | 627 | 843 | 521 | 675 | 757 |
| Long-term debt | 0 | -16 | 0 | 182 | 0 | 0 | 0 | 55 | 123 | 0 | 0 | 0 | 0 |
| Short-term debt | 158 | 219 | 189 | 272 | 362 | 199 | 240 | 318 | 497 | 435 | 483 | 299 | 355 |
| Total debt | 158 | 219 | 189 | 454 | 362 | 199 | 240 | 373 | 620 | 435 | 483 | 299 | 355 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20122024
Equity ratio
68.0%
This company
38.2%
Market median
+78% vs market
20122024
Return on equity
10.9%
This company
18.4%
Market median
+41% vs market
20122024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20122024
Asset turnover
2.15×
This company
1.12×
Market median
+92% vs market
20122024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KJ Management | Management | 2017 | — | — |
AS Founder | Founder | 2005 | — | — |
HK | Founder | 2005 | — | — |
KC Management | Management | 2012 | — | — |
JJ Founder | Founder | 2005 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KJKS Holding ApS | Company | 66.7% | 66.7% | 2025 |
| Individual | 20.0% | 20.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KJKS Holding ApS
NEUROKLINIK ApS Board members of NEUROKLINIK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kaare Julian Kirketerp Stensgaard | Management | 0 companies |
| Ahmad Shayan | Founder | 0 companies |
| Heidi Karina Serritslev Zachariasen | Founder | 0 companies |
| Karen Clausen | Management | 0 companies |
| Jim Jensen | Founder | 0 companies |